Document Detail

Estrogen blocks neurotoxic effects of beta-amyloid (1-42) and induces neurite extension on B103 cells.
MedLine Citation:
PMID:  9406879     Owner:  NLM     Status:  MEDLINE    
Clinical studies have shown that estrogen replacement therapy is associated with reduced risk of Alzheimer's disease (AD). We tested whether or not estrogen blocks neurotoxic effects of beta-amyloid (1-42) (A beta1-42) on cultured B103 cells. A beta1-42 (1 microM) induced typical necrotic cell death, as revealed by light and electron microscopic examinations. Co-administration of estrogen not only blocked A beta1-42 toxicity to a large degree, but also enhanced neurite extension. Pretreatment with estrogen was even more effective in blocking A beta1-42 toxicity. When added 18 h after the beginning of A beta1-42 treatment, estrogen was still effective in halting the progress of cell death and enhancing neurite extension. The protection against A beta1-42-induced neuronal death by estrogen was unlikely due to a blockade of lipid peroxidation injury, since estrogen completely failed to attenuate ferrous chloride-induced cell death. These results demonstrate that estrogen blocks A beta1-42-induced neurotoxicity and enhances neurite extension on B103 cells, both of which may well be underlying mechanisms of beneficial effects of estrogen in AD.
I Mook-Jung; I Joo; S Sohn; H J Kwon; K Huh; M W Jung
Related Documents :
12402979 - The activity of bisphenol a depends on both the estrogen receptor subtype and the cell ...
20833159 - Brassinosteroids cause cell cycle arrest and apoptosis of human breast cancer cells.
1337629 - Expression of urokinase and its receptor in invasive and non-invasive prostate cancer c...
16128989 - Androgens induce cd-9 in human prostate tissue.
109329 - Hormonal regulation in two rat mammary cancer cell lines: glucocorticoid and androgen r...
19891779 - A selective eradication of human nonhereditary breast cancer cells by phenanthridine-de...
21565279 - Methodological proof of immunochemistry for specific identification of 8-nitroguanosine...
2310369 - A new method to monitor kupffer-cell function continuously in the perfused rat liver. d...
17277079 - Light-powering escherichia coli with proteorhodopsin.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Neuroscience letters     Volume:  235     ISSN:  0304-3940     ISO Abbreviation:  Neurosci. Lett.     Publication Date:  1997 Oct 
Date Detail:
Created Date:  1998-01-29     Completed Date:  1998-01-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7600130     Medline TA:  Neurosci Lett     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  101-4     Citation Subset:  IM    
Department of Neurology, School of Medicine, Institute for Medical Sciences, Ajou University, Suwon, South Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amyloid beta-Protein / antagonists & inhibitors,  toxicity*
Brain / cytology,  drug effects*
Cell Line
Estrogens / pharmacology*
Neurites / drug effects*
Neurons / drug effects*,  ultrastructure
Neurotoxins / toxicity*
Peptide Fragments / antagonists & inhibitors,  toxicity*
Reg. No./Substance:
0/Amyloid beta-Protein; 0/Estrogens; 0/Neurotoxins; 0/Peptide Fragments; 0/amyloid beta-protein (1-42)

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A search for primitive Purkinje cells: zebrin II expression in sea lampreys (Petromyzon marinus).
Next Document:  Human brain potentials to reading syntactic errors in sentences of different complexity.